Latvia vs Morocco: Cause of death, by non-communicable diseases, ages 5-14, female
Latvia
49.5%
in 2021
Morocco
47.6%
in 2021
Latvia rank
63rd
Morocco rank
66th
Cause of death, by non-communicable diseases, ages 5-14, female over time
- Latvia
- Morocco
How they compare
Latvia currently reports 49.5% against 47.6% in Morocco, a difference of 1.9%.
Across all 6 years both countries report, Latvia has been ahead every year.
Latvia ranks 63rd and Morocco ranks 66th of 184 countries.
Latvia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Latvia | Morocco | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 47.1% | 23.6% | 23.4% | Latvia |
| 2010s | 47.3% | 43.6% | 3.8% | Latvia |
| 2020s | 52.6% | 47.1% | 5.5% | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, female, Latvia or Morocco?
- Latvia, at 49.5% against 47.6% in Morocco as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, female between Latvia and Morocco?
- 1.9%, with Latvia ahead.
- How many years of comparable data are there for Latvia and Morocco?
- 6 years are reported by both, from 2000 to 2021.
- How do Latvia and Morocco rank globally for cause of death, by non-communicable diseases, ages 5-14, female?
- Latvia ranks 63rd and Morocco ranks 66th of 184 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, female (% of total female deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 5-14 due to non-communicable diseases divided by number of all female deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.